The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $109.80

Today's change-0.13 -0.12%
Updated July 20 10:43 AM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $109.80

Today's change-0.13 -0.12%
Updated July 20 10:43 AM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc down (U.S.)$0.13

Quest Diagnostics Inc is lower today, dropping (U.S.)$0.13 or 0.12% to (U.S.)$109.80. Over the last five days, shares have gained 1.04% and are currently 2.80% off of the 52-week high. Shares have outperformed the S&P 500 by 17.69% during the last year.

Key company metrics

  • Open(U.S.) $110.05
  • Previous close(U.S.) $109.93
  • High(U.S.) $110.33
  • Low(U.S.) $109.56
  • Bid / Ask(U.S.) $109.77 / (U.S.) $109.81
  • YTD % change+19.48%
  • Volume145,504
  • Average volume (10-day)741,463
  • Average volume (1-month)842,968
  • Average volume (3-month)880,784
  • 52-week range(U.S.) $79.12 to (U.S.) $112.97
  • Beta0.69
  • Trailing P/E21.98×
  • P/E 1 year forward19.75×
  • Forward PEG2.62×
  • Indicated annual dividend(U.S.) $1.80
  • Dividend yield1.64%
  • Trailing EPS(U.S.) $5.00
Updated July 20 10:43 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue1,8991,8611,8851,906
Total other revenue--------
Total revenue1,8991,8611,8851,906
Gross profit736760729753
Total cost of revenue1,1631,1011,1561,153
Total operating expense1,6201,5851,5631,484
Selling / general / administrative436363407429
Research & development--------
Depreciation / amortization17181817
Interest expense (income), net operating--------
Unusual expense (income)3963-115
Other operating expenses, total17-210
Operating income279276322422
Interest income (expense), net non-operating-37-36-37-35
Gain (loss) on sale of assets--------
Other--------
Income before tax253251300392
Income after tax175167205209
Income tax, total788495183
Net income164155192195
Total adjustments to net income--0-2-1
Net income before extra. items164155192195
Minority interest-11-12-13-14
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items164155190194
Inc. avail. to common incl. extra. items164155190194
Diluted net income164155192194
Dilution adjustment----2--
Diluted weighted average shares141139142142
Diluted EPS excluding extraordinary itemsvalue per share1.161.121.351.37
Dividends per sharevalue per share0.450.400.400.40
Diluted normalized EPSvalue per share1.181.571.370.93